Insight 2811, Inc.'s Q3 and Q4 2022 Holdings Comparison: Notable Shifts in Investments

Insight 2811, Inc. is a well-established investment fund that specializes in finding unique and innovative investment opportunities. To get a better understanding of the funds' performance, we will take a closer look at their Q3 2022 and Q4 2022 13F holdings comparison.

The holdings reported in the 13F filings show the fund's investments in public companies as of the end of the quarter. The filings are useful in tracking the fund's portfolio and identifying changes that may indicate the fund's strategy is shifting.

As we examine the data provided in the comparison, it is clear that some significant changes have occurred in the fund's holdings over the two quarters.

One of the most notable changes was the reduction in the number of shares held by the fund in ISHARES TR, the sponsor of the iShares exchange-traded funds (ETFs). In Q3 2022, the fund held 550,887 shares of ISHARES TR. However, in Q4 2022, this number dropped by 16.8% to 458,619 shares. The value of the shares held by the fund also saw a decline from $44,737,000 in Q3 2022 to $37,226,000 in Q4 2022, representing a 16.8% decline.

Another interesting change was the shift in the fund's holdings in J P Morgan Exchange-Traded Fund Trust, which owns shares of various J.P. Morgan ETFs. At the end of Q3 2022, the fund held 41,033 shares of the J.P. Morgan fund. However, by the end of Q4 2022, the number of shares held by the fund had dropped by 16.7% to 34,187. Similarly, the value of these shares held by the fund decreased from $2,058,000 in Q3 2022 to $1,714,000 in Q4 2022.

The fund also increased its holdings in several companies in Q4 2022. The fund increased the number of shares of Johnson & Johnson (JNJ) by 12.3% from 5,768 shares in Q3 2022 to 6,471 shares in Q4 2022. The value of these shares also increased from $942,000 in Q3 2022 to $1,143,000 in Q4 2022, representing a 21.3% increase.

Similarly, the fund increased its holdings in Merck & Co. Inc(NYSE:MRK) by 12.5% percent from 8,286 shares in Q3 2022 to 9,372 shares in Q4 2022. The value of these shares increased from $714,000 in Q3 2022 to $1,040,000 in Q4 2022, representing a 45.7% increase.

The fund also increased its holdings in Allstate Corp(NYSE:ALL) by 0.04%, from 2,816 shares in Q3 2022 to 2,815 in Q4 2022. The value of these shares increased from $351,000 in Q3 2022 to $382,000 in Q4 2022, representing an 8.8% increase.

The fund's holdings in Berkshire Hathaway Inc (NYSE:BRK-B) also increased by 9.7%, from 4,169 shares in Q3 2022 to 4,537 shares in Q4 2022. The value of these shares increased from $1,113,000 in Q3 2022 to $1,401,000 in Q4 2022, representing a 25.9% increase.

Overall, Insight 2811, Inc. made significant changes to its holdings in Q4 2022, with an emphasis on increasing holdings in Johnson & Johnson, Merck & Co. Inc, Allstate Corp, and Berkshire Hathaway Inc. It is noteworthy that the fund decreased its holdings in ISHARES TR and J P Morgan Exchange-Traded Fund Trust.

It is essential to note that investing involves risk, and past performance is not always indicative of future results. Therefore, it is always essential to consult with a financial advisor before making any investment decisions.